Daniel Ghyssels

VP, Commercial Europe at Immunocore

Speaker

Daniel Ghyssels is Vice President Commercial Europe at Immunocore, pioneers of the world’s first T cell receptor therapy. Immunocore’s mission is to radically improve outcomes for patients with cancer, infectious diseases, and auto-immune diseases by pioneering and delivering transformative immunomodulating medicines.

Daniel has been working in the pharmaceutical industry since 2005. He has held positions as Franchise Business Leader Immune-Oncology, Europe and Canada at Astra Zeneca. He also worked in 3 different European countries , including Germany, in various marketing and business roles at Amgen.

Daniel has broad experience in organizational design, go-to-market strategy. He has worked on the launch of more than 10 treatments over time.

Daniel holds a degree in pharmaceutical sciences and has postgraduates in business administration, corporate finance and pharmaco-economics.